Burlington, NJ, United States of America

Brian T Campbell

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 8.9

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • San Diego, CA (US) (2006 - 2011)
  • Burlington, NY (US) (2016)
  • Burlington, NJ (US) (2013 - 2018)
  • Bensalem, PA (US) (2016 - 2021)
  • Souderton, PA (US) (2022)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: The Innovative Contributions of Brian T. Campbell

Introduction: Brian T. Campbell, an esteemed inventor based in Burlington, NJ, has made significant strides in the field of pharmacology with a remarkable portfolio of 16 patents. His innovative work primarily focuses on developing allosteric modulators of nicotinic acetylcholine receptors, which hold promise for treating various central nervous system disorders.

Latest Patents: Among Brian’s latest patents, two notable inventions stand out. The first patent describes spiropiperidine allosteric modulators of nicotinic acetylcholine receptors. This invention relates to compounds effective in modulating the α7 nAChR, with potential applications in preventing, treating, or ameliorating diseases such as cognitive impairments in Alzheimer’s disease, Parkinson’s disease, schizophrenia, L-DOPA induced dyskinesia, and inflammation. The second patent features substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors. Similar to the first patent, this invention aims to address multiple central nervous system disorders, further underscoring his commitment to enhancing therapeutic options for patients.

Career Highlights: Throughout his career, Brian T. Campbell has made notable contributions while working with renowned companies such as Merck Sharp & Dohme Corporation and Ambit Biosciences Corporation. His commitment to research and development has led to innovations with far-reaching impacts on healthcare.

Collaborations: Brian has collaborated with a number of talented professionals, including Sunny Abraham and Shripad S. Bhagwat. These collaborations have likely enriched his research efforts and facilitated knowledge exchange that drives innovation forward.

Conclusion: Brian T. Campbell's inventive prowess has positioned him as a key contributor to advancements in the treatment of central nervous system disorders. With a robust portfolio of patents and a background in influential companies, his work continues to pave the way for innovative therapies that enhance patient care and quality of life.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…